AGTX — Agentix Income Statement
0.000.00%
- $1.00m
- $1.24m
Annual income statement for Agentix, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2021 August 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 7 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-KT | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.001 | 0 | 0 | 0 | 0 |
Cost of Revenue | |||||
Gross Profit | 0.001 | 0 | 0 | — | — |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Total Operating Expenses | 1.34 | 2.29 | 1.37 | 0.745 | 0.513 |
Operating Profit | -1.34 | -2.29 | -1.37 | -0.745 | -0.513 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -1.34 | -2.29 | -1.37 | -0.585 | -0.567 |
Provision for Income Taxes | |||||
Net Income After Taxes | -1.34 | -2.29 | -1.37 | -0.585 | -0.567 |
Net Income Before Extraordinary Items | |||||
Net Income | -1.34 | -2.29 | -1.37 | -0.585 | -0.567 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -1.34 | -2.29 | -1.37 | -0.585 | -0.567 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.039 | -0.063 | -0.035 | -0.015 | -0.014 |
Dividends per Share |